文献速递血栓与止血

血涂片诊断遗传性血小板疾病:一种促进全球血小板疾病诊断的工具

Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders.
PubMed 文献 · J Thromb Haemost · 2017-06-04

该国际合作研究利用不足100微升血液制备的血涂片,经免疫荧光标记,对3217例疑似遗传性血小板疾病患者进行血小板表型系统诊断,在877/3217(27%)例中明确了潜在病因,尤其有助于识别MYH9疾病、双等位基因Bernard-Soulier综合征、Glanzmann血小板无力症和灰色血小板综合征。该方法结合广泛可用的基础样本前处理与免疫形态学技术,支持基因检测并促进全球各年龄段患者的诊断。

要点

  • 血涂片免疫荧光法可在877/3217(27%)例疑似遗传性血小板疾病患者中明确病因。
  • 该方法对MYH9疾病、双等位基因Bernard-Soulier综合征、Glanzmann血小板无力症和灰色血小板综合征识别尤为有帮助。
  • 仅需不足100微升血液,血涂片可本地制备并普通邮寄至中心实验室检测。

核心结论

  • 结合基础且广泛可用的样本前处理方法与本文展示的免疫形态学技术,可对血小板表型进行详细表征,支持基因检测并促进全球各年龄段遗传性血小板疾病患者的诊断。

研究设计与样本

  • 由四个中心协作的国际合作方法学研究,采用本地制备、普通邮寄至中心实验室的标准化空气干燥外周血涂片(不足100微升血液)进行免疫荧光标记。
  • 纳入3217例疑似遗传性血小板疾病患者,通过免疫荧光标记血涂片系统诊断以表征血小板表型。

主要发现

  • 通过血涂片免疫荧光标记,在877/3217(27%)例疑似遗传性血小板疾病患者中明确了潜在病因。
  • 目前约识别出50种遗传性血小板疾病的遗传病因。
  • 血涂片方法对识别MYH9疾病/MYH9相关疾病、双等位基因Bernard-Soulier综合征、Glanzmann血小板无力症和灰色血小板综合征尤为有帮助。
  • 诊断还可确立于GATA1巨血小板减少症、GFI1B巨血小板减少症、β1-微管蛋白巨血小板减少症、filamin A相关血小板减少症和Wiskott-Aldrich综合征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials There are many hereditary platelet disorders (HPD) but diagnosing these is challenging. We provide a method to diagnose several HPDs using standard blood smears requiring < 100 µL blood. By this approach, the underlying cause of HPD was characterized in ~25-30% of referred individuals. The method facilitates diagnosis of HPD for patients of all ages around the world. SUMMARY: Background Many hereditary thrombocytopenias and/or platelet function disorders have been identified, but diagnosis of these conditions remains challenging. Diagnostic laboratory techniques are available only in a few specialized centers and, using fresh blood, often require the patient to travel long distances. For the same reasons, patients living in developing countries usually have limited access to diagnosis. Further, the required amount of blood is often prohibitive for pediatric patients. Objectives By a collaborative international approach of four centers, we aimed to overcome these limitations by developing a method using blood smears prepared from less than 100 μL blood, for a systematic diagnostic approach to characterize the platelet phenotype. Methods We applied immunofluorescence labelling (performed centrally) to standard air-dried peripheral blood smears (prepared locally, shipped by regular mail), using antibodies specific for proteins known to be affected in specific hereditary platelet disorders. Results By immunofluorescence labelling of blood smears we characterized the underlying cause in 877/3217 (27%) patients with suspected hereditary platelet disorders (HPD). Currently about 50 genetic causes for HPD are identified. Among those, the blood smear method was especially helpful to identify MYH9 disorders/MYH9-related disease, biallelic Bernard-Soulier syndrome, Glanzmann thrombasthenia and gray platelet syndrome. Diagnosis could be established for GATA1 macrothrombocytopenia, GFI1B macrothrombocytopenia, ß1-tubulin macrothrombocytopenia, filamin A-related thrombocytopenia and Wiskott-Aldrich syndrome. Conclusion Combining basic and widely available preanalytical methods with the immunomorphological techniques presented here, allows detailed characterization of the platelet phenotype. This supports genetic testing and facilitates diagnosis of hereditary platelet disorders for patients of all ages around the world.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Greinacher A, Pecci A, Kunishima S, et al. Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders. J Thromb Haemost. 2017. PMID: 28457011. doi:10.1111/jth.13729

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。